scholarly journals The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry

2021 ◽  
Author(s):  
Hyeong In Ha ◽  
Ha Kyun Chang ◽  
Soo Jin Park ◽  
Jiwon Lim ◽  
Young-Joo Won ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Cancer Registry ◽  
Central Cancer Registry

scholarly journals Trends of lymphoma incidence in US veterans with rheumatoid arthritis, 2002–2017

RMD Open ◽  
2020 ◽  
Vol 6 (2) ◽  
pp. e001241
Author(s):  
Namrata Singh ◽  
Yubo Gao ◽  
Elizabeth Field ◽  
Brian K Link ◽  
Noel Weiss ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Disease Activity ◽  
Data Warehouse ◽  
Cancer Registry ◽  
Epidemiological Studies ◽  
Veterans Affairs ◽  
Recent Trends ◽  
Specific Factors ◽  
Us Veterans ◽  
Central Cancer Registry

ObjectivePast epidemiological studies have consistently demonstrated a link between rheumatoid arthritis (RA) and the incidence of lymphoma and it has been posited that high systemic inflammatory activity is a major risk determinant of lymphomagenesis. Given advances in the therapeutic armamentarium for RA management in recent years, the resulting lower level of disease activity could have led to a decline in lymphoma incidence in patients with RA. This study examined recent trends in lymphoma incidence in US veterans with RA.MethodsPatients with RA were identified in the Veterans Affairs (VA) Corporate Data Warehouse. Lymphoma incidence was identified through the end of 2018 from the VA Central Cancer Registry and compared among patients diagnosed during 2003–2005, 2006–2008, 2009–2011 and 2012–2014.ResultsAmong persons diagnosed with RA during 2003–2005, the incidence of lymphoma in the next 6 years was 2.0 per 1000 person-years. There was a steady decline in lymphoma incidence during the corresponding 6 years following diagnosis in the subsequent three cohorts, with a rate of 1.5 per 1000 person-years in the 2012–2014 cohort (incidence relative to that in the 2003–2005 cohort=0.79 (95% CI 0.58 to 1.1)). There was no similar decline in lymphoma incidence in VA patients diagnosed with osteoarthritis.ConclusionWe observed a decline in lymphoma incidence in recent years among American veterans with RA. Further studies are needed to evaluate the specific factors driving this decline.

Difficulties and Results of Endometrial Cancer Registration by a Cancer Registry

2015 ◽  
pp. 5-11
Author(s):  
R. Schaerer ◽  
F. Menegoz ◽  
J. M. Lutz ◽  
P. Swiercz ◽  
M. Mousseau
Keyword(s):  
Endometrial Cancer ◽  
Cancer Registry ◽  
Cancer Registration

Does post-operative radiochemotherapy improve survival in high-grade endometrial cancer patients? Results of a population-based cohort analysis of a cancer registry

2018 ◽  
Vol 297 (5) ◽  
pp. 1245-1253 ◽  
Author(s):  
Sophia Scharl ◽  
Thomas Papathemelis ◽  
Karin Kronberger ◽  
Michael Gerken ◽  
Anton Scharl ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Cancer Patients ◽  
Cancer Registry ◽  
Cohort Analysis ◽  
Population Based ◽  
High Grade

scholarly journals Second primary cancers in patients with oral cavity cancer included in the Korea Central Cancer Registry

Oral Oncology ◽  
2019 ◽  
Vol 95 ◽  
pp. 16-28 ◽  
Author(s):  
Seung-Ki Min ◽  
Sung Weon Choi ◽  
Jiwon Lim ◽  
Joo Yong Park ◽  
Kyu-Won Jung ◽  
...  
Keyword(s):  
Oral Cavity ◽  
Cancer Registry ◽  
Oral Cavity Cancer ◽  
Second Primary ◽  
Second Primary Cancers ◽  
Central Cancer Registry

scholarly journals 2001 Annual Report of the Korea Central Cancer Registry: Based on Registered Data from 134 Hospitals

2004 ◽  
Vol 36 (1) ◽  
pp. 19 ◽  
Author(s):  
Hai-Rim Shin ◽  
Young-Joo Won ◽  
Kyu-Won Jung ◽  
Jae-Gahb Park
Keyword(s):  
Cancer Registry ◽  
Annual Report ◽  
Central Cancer Registry

scholarly journals Comparing the Characteristics and Outcomes of Male and Female Breast Cancer Patients in Korea: Korea Central Cancer Registry

2020 ◽  
Vol 52 (3) ◽  
pp. 739-746
Author(s):  
Eun-Gyeong Lee ◽  
So-Youn Jung ◽  
Myong Cheol Lim ◽  
Jiwon Lim ◽  
Han-Sung Kang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Registry ◽  
Female Breast Cancer ◽  
Older Age ◽  
Survival Outcomes ◽  
Histological Types ◽  
Female Breast ◽  
Male Patients ◽  
To Receive ◽  
Central Cancer Registry

PurposeThis study aimed to determine the incidence of male breast cancer (MBC) and its survival outcomes in Korea, and to compare these results to those for female breast cancer (FBC).Materials and MethodsWe searched the Korea Central Cancer Registry and identified 227,122 breast cancer cases that were diagnosed between 1999 and 2016. Demographic and clinical characteristics and overall survival (OS) rates were estimated according to sex, age, histological type, and cancer stage.ResultsThe 227,122 patients included 1,094 MBC cases and 226,028 FBC cases. Based on the age-standardized rate, the male: female ratio was 0.0055:1. The most common ages at diagnosis were 60-69 years for MBC and 40-49 years for FBC (p < 0.001). Male patients were less likely than female patients to receive adjuvant radiotherapy (7.5% vs. 21.8%, p < 0.001) or adjuvant chemotherapy (40.1% vs. 55.4%, p < 0.001). The 5-year OS rates after diagnosis were 88.8% for all patients, although it was significantly lower for MBC than for FBC (76.2% vs. 88.9%, p < 0.001). In both groups, older age (≥ 60 years) was associated with shorter survival. The 5-year OS rates for the invasive histological types were 75.8% for men and 89.0% for women. The 5-year OS rates in both groups decreased with increasing cancer stage.ConclusionMBC was diagnosed at older ages than FBC, and male patients were less likely to receive radiotherapy and chemotherapy. The survival outcomes were worse for MBC than for FBC, with even poorer outcomes related to older age, the inflammatory histological types, and advanced stage. It is important that clinicians recognize the differences between FBC and MBC when treating these patients.

Sign in / Sign up

Export Citation Format

Share Document